Category: Inflammation

Acute blood biomarker profiles predict cognitive deficits 6 and 12 months after COVID-19 hospitalization

Posted on | Posted on jmurphy | Leave a Comment on Acute blood biomarker profiles predict cognitive deficits 6 and 12 months after COVID-19 hospitalization

Maxime Taquet, Zuzanna Skorniewska, Adam Hampshire, James D. Chalmers, Ling-Pei Ho, Alex Horsley, Michael Marks, Krisnah Poinasamy, Betty Raman, Olivia C. Leavy, Matthew Richardson, Omer Elneima, Hamish J. C. McAuley, Aarti Shikotra, Amisha Singapuri, Marco Sereno, Ruth M. Saunders, Victoria C. Harris, Linzy Houchen-Wolloff, Neil J. Greening, Parisa Mansoori, Ewen M. Harrison, Annemarie B. Docherty, Nazir I. Lone, PHOSP-COVID Study Collaborative Group Nature Medicine (August 2023)  Abstract Post-COVID cognitive deficits, including ‘brain fog’, are clinically complex, with both objective and […]

Predictive Role of Biomarkers in COVID-19 Mortality

Posted on | Posted on jmurphy | Leave a Comment on Predictive Role of Biomarkers in COVID-19 Mortality

Ayşe Yılmaz,1 Öztürk Taşkın,1 Ufuk Demir,1 and Veysel G Soylu2 Cureus. 2023 Jan; 15(1): e34173. Published online 2023 Jan 24 doi: 10.7759/cureus.34173 PMCID: PMC9950690PMID: 36843833 Abstract Background The coronavirus disease 2019 (COVID-19) pandemic has resulted in high mortality among patients in critical intensive care units. Hence, identifying mortality markers in the follow-up and treatment of these patients is essential. This study aimed to evaluate […]

What to Know About ADHD and Brain Fog

Posted on | Posted on jmurphy | Leave a Comment on What to Know About ADHD and Brain Fog

Attention deficit hyperactivity disorder (ADHD) can have a big impact on your ability to think clearly. In fact, ADHD can sometimes make you feel as though a fog has seeped into your brain. Your reaction time slows. It can be harder to recall information, process your thoughts, and find the right words to say what […]

COVID-19 and neurological disorders: what might connect Parkinson’s disease to SARS-CoV-2 infection

Posted on | Posted on jmurphy | Leave a Comment on COVID-19 and neurological disorders: what might connect Parkinson’s disease to SARS-CoV-2 infection

Salvatore Iacono1† Giuseppe Schirò1† Chiara Davì1 Sergio Mastrilli2 Michelle Abbott3 Fabrizio Guajana1 Valentina Arnao4 Paolo Aridon1 Paolo Ragonese1 Cesare Gagliardo1 Claudia Colomba3 Nicola Scichilone5 Marco D’Amelio1* Front. Neurol., 18 May 2023 Sec. Movement Disorders Volume 14 – 2023 | https://doi.org/10.3389/fneur.2023.1172416 SARS-CoV-2 infection leading to Coronavirus disease 19 (COVID-19) rapidly became a worldwide health emergency due to its elevated infecting capacity, morbidity, and mortality. Parkinson’s disease (PD) is the […]

Long COVID Now Looks like a Neurological Disease, Helping Doctors to Focus Treatments

Posted on | Posted on jmurphy | Leave a Comment on Long COVID Now Looks like a Neurological Disease, Helping Doctors to Focus Treatments

The causes of long COVID, which disables millions, may come together in the brain and nervous system Stephani Sutherland on March 1, 2023 Tara Ghormley has always been an overachiever. She finished at the top of her class in high school, graduated summa cum laude from college and earned top honors in veterinary school. She went on […]

What Is Interstitial Lung Disease?

Posted on | Posted on jmurphy | Leave a Comment on What Is Interstitial Lung Disease?

By Lana Barhum  November 16, 2022  Medically reviewed by Susan Russell, MD Interstitial lung disease (ILD) includes more than 200 conditions that cause inflammation and scarring of lung tissue.1 The damage done by interstitial lung disease makes it harder for oxygen to enter the bloodstream from the air sacs of the lungs. The prevalence of ILD in the US is […]

An Approach to Treating Long COVID

Posted on | Posted on jmurphy | Leave a Comment on An Approach to Treating Long COVID

August 8, 2023 Due to the marked overlap between long COVID and post-vaccine syndrome, please refer to the I-RECOVER Post-Vaccine Treatment protocol for detailed treatment strategies. This page highlights the differences between these two syndromes, namely ongoing organizing pneumonia. About Long COVID Long COVID, also known as Long Haul COVID Syndrome (LHCS) and more recently […]

How COVID-19 causes neurological damage

Posted on | Posted on jmurphy | Leave a Comment on How COVID-19 causes neurological damage

Authors: Date:nnNovember 14, 2022 University of Basel Summary:It’s not uncommon for people to lose their sense of taste and smell due to a COVID-19 infection. In others, the disease has had an even stronger impact on the nervous system, with effects ranging from lasting concentration problems to strokes. Now, researchers have reported new insights into […]

COVID-19 inflammation results in urine cytokine elevation and causes COVID-19 associated cystitis (CAC)

Posted on | Posted on jmurphy | Leave a Comment on COVID-19 inflammation results in urine cytokine elevation and causes COVID-19 associated cystitis (CAC)

Authors: Laura E Lamb 1, Nivedita Dhar 2, Ryan Timar 3, Melissa Wills 3, Sorabh Dhar 4, Michael B Chancellor 5 PMID: 33213997 PMCID: PMC7644255 DOI: 10.1016/j.mehy.2020.110375 Abstract Coronavirus disease 2019 (COVID-19) causes a wide range of symptoms, including several unexpected symptoms such as loss of taste, skin changes, and eye problems. We recently observed patients with documented COVID-19 develop de novo severe genitourinary symptoms, most notably urinary frequency […]

Auditory Disturbances and SARS-CoV-2 Infection: Brain Inflammation or Cochlear Affection? Systematic Review and Discussion of Potential Pathogenesis

Posted on | Posted on jmurphy | Leave a Comment on Auditory Disturbances and SARS-CoV-2 Infection: Brain Inflammation or Cochlear Affection? Systematic Review and Discussion of Potential Pathogenesis

Pietro De Luca1, Alfonso Scarpa1, Massimo Ralli2, Domenico Tassone3, Matteo Simone3, Luca De Campora3, Claudia Cassandro4† and Arianna Di Stadio Frontiers in Medicine Patients affected by COVID-19 present a series of different symptoms; despite some of these are common, other less likely appear. Auditory symptoms seem to be less frequent, maybe because rarer or, alternatively, because they are underestimated during the clinical investigation. […]